A Whole-Genome Assembly of Drosophila
We report on the quality of a whole-genome assembly ofDrosophila melanogaster and the
nature of the computer algorithms that accomplished it. Three independent external data …
nature of the computer algorithms that accomplished it. Three independent external data …
[HTML][HTML] Tumor-associated macrophages in osteosarcoma: from mechanisms to therapy
F Cersosimo, S Lonardi, G Bernardini, B Telfer… - International journal of …, 2020 - mdpi.com
Osteosarcomas (OSs) are bone tumors most commonly found in pediatric and adolescent
patients characterized by high risk of metastatic progression and recurrence after therapy. …
patients characterized by high risk of metastatic progression and recurrence after therapy. …
A physical, genetic and functional sequence assembly of the barley genome.
…, M Groth, M Platzer, A Himmelbach, S Lonardi… - Nature, 2012 - iris.unito.it
Barley (Hordeum vulgare L.) is among the world's earliest domesticated and most important
crop plants. It is diploid with a large haploid genome of 5.1 gigabases (Gb). Here we present …
crop plants. It is diploid with a large haploid genome of 5.1 gigabases (Gb). Here we present …
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre …
MJ Overman, R McDermott, JL Leach, S Lonardi… - The lancet …, 2017 - thelancet.com
Background Metastatic DNA mismatch repair-deficient (dMMR)/microsatellite instability-high
(MSI-H) colorectal cancer has a poor prognosis after treatment with conventional …
(MSI-H) colorectal cancer has a poor prognosis after treatment with conventional …
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
YY Janjigian, A Kawazoe, P Yañez, N Li, S Lonardi… - Nature, 2021 - nature.com
Human epidermal growth factor receptor 2 (HER2, also known as ERBB2) amplification or
overexpression occurs in approximately 20% of advanced gastric or gastro-oesophageal …
overexpression occurs in approximately 20% of advanced gastric or gastro-oesophageal …
[HTML][HTML] A chromosome conformation capture ordered sequence of the barley genome
… food crop, recent excavations have fuelled speculation that beverages from fermented grains
may have motivated early Neolithic hunter–gatherers to erect some of humankind’s oldest …
may have motivated early Neolithic hunter–gatherers to erect some of humankind’s oldest …
A symbolic representation of time series, with implications for streaming algorithms
… There is a simple explanation for the data mining community’s lack of interest in symbolic
manipulation as a supporting technique for mining time series. If the data are transformed into …
manipulation as a supporting technique for mining time series. If the data are transformed into …
[HTML][HTML] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
…, P Pfeiffer, S Orlov, S Lonardi… - … England Journal of …, 2019 - Mass Medical Soc
Background Patients with metastatic colorectal cancer with the BRAF V600E mutation have
a poor prognosis, with a median overall survival of 4 to 6 months after failure of initial therapy…
a poor prognosis, with a median overall survival of 4 to 6 months after failure of initial therapy…
Experiencing SAX: a novel symbolic representation of time series
… There is, however, a simple explanation for the data mining community’s lack of interest
in string manipulation as a supporting technique for mining time series. If the data are …
in string manipulation as a supporting technique for mining time series. If the data are …
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and …
…, C Antoniotti, C Lupi, E Sensi, S Lonardi, S Mezi… - The Lancet …, 2015 - thelancet.com
Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and
irinotecan) plus bevacizumab significantly improved progression-free survival of patients with …
irinotecan) plus bevacizumab significantly improved progression-free survival of patients with …